Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 22 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-22-2021-4

Cadila Healthcare Limited has informed the Exchange regarding a press release dated October 22, 2021, titled " Zydus announces first patient randomised in EVIDENCES-XTM Phase II(b) clinical trial of Saroglitazar Mg in NASH ".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases